Skip to main content
RT @synovialjoints: Treatment for VEXAS syndrome. It is steroid responsive. Avoid IL-1 inhibitors severe skin reactions

Dr. Antoni Chan synovialjoints

4 years 10 months ago
Treatment for VEXAS syndrome. It is steroid responsive. Avoid IL-1 inhibitors severe skin reactions at injection site, bone marrow transplant may be curative @RheumNow #ACR21 Session6S410 L Wilson, DO Cordona https://t.co/eQ1KVDiKKV
RT @ELittlejohnDO: Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheuma

Emily Littlejohn ELittlejohnDO

4 years 10 months ago
Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheumatic Diseases. A wonderful resource in talking to our patients about vaccine necessity! @CleClinicMD https://t.co/EA5jVYweHm
RT @ERheumat: #ACR21 #ACR2021 Clinical Pearls
🚨 Thread Alert
1/n
💥AAV does not typically cause hard palate lesio

EnvisionRheumat ERheumat

4 years 10 months ago
#ACR21 #ACR2021 Clinical Pearls 🚨 Thread Alert 1/n 💥AAV does not typically cause hard palate lesions➡️consider: Cocaine induced midline destructive lesion(HNE+)/Malignancy 💥Limited GPA can be ANCA negetive in 50% 💥 oral cavity examination is a must in Rheum https://t.co/RxkLiGdcJt
RT @ERheumat: #ACR21 #ACR2021
Sjogrens syndrome with pulmonary involvement guidelines
🚨Thread Alert
👉🏻Screen a

EnvisionRheumat ERheumat

4 years 10 months ago
#ACR21 #ACR2021 Sjogrens syndrome with pulmonary involvement guidelines 🚨Thread Alert 👉🏻Screen all patients for pulm inv. irrespective of symtopms ➡️ prevlance of lung involvement can be upto 65% 👉🏻Complete PFT includes ➡️ Spirometry➕ DLCO➕ PuseOximetry https://t.co/prFgQESRyF
RT @AshimaMakol: Targeting the HUGE dilemma!🎯

#Psoriatic vs Erosive #OA

PsA
👉 Fluffy bone formation(enthesitis

Ashima Makol MD AshimaMakol

4 years 10 months ago
Targeting the HUGE dilemma!🎯 #Psoriatic vs Erosive #OA PsA 👉 Fluffy bone formation(enthesitis of phalanges) 👉 Marginal erosions(vs central) 👉 Many jts in same digit(ray inv) 👉 Periarticular SOFT tissue swelling (dactylitis). 👉 NOT much hand OA #ACR21 RadiologyBootCamp https://t.co/OQLPoeRLny
RT @BolekBerqui: Live from #ACR21:
Learning about osteoarthritis from Dr. Marc Hochberg.

"Don't use the term degenerati

Jilaine Bolek Berquist BolekBerqui

4 years 10 months ago
Live from #ACR21: Learning about osteoarthritis from Dr. Marc Hochberg. "Don't use the term degenerative joint disease." -much more involved. I like this figure of the multiple different phenotypes. #ACRAmbassador https://t.co/UwU4vCmYXa
RT @MithuRheum: #ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri &

Mithu Maheswaranathan, MD MithuRheum

4 years 10 months ago
#ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri & Dr. Rovin Audience Vote 🗳: What would you add to mycophenolate first? Belimumab 71%, Voclosporin 29% #ACRAmbassador @ACRheum Summary of Pros & Cons of Each⬇️ https://t.co/OtLxs8IYr9
RT @ericdeinmd: #ACR21 TM24. Hydralazine-induced ANCA vasculitis presenting with chondritis.
Labs:
+ANA
+Anti-histone
+

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 TM24. Hydralazine-induced ANCA vasculitis presenting with chondritis. Labs: +ANA +Anti-histone +p-ANCA, +MPO and +PR3 @Rheumnow https://t.co/YQvqj0vCHp https://t.co/LPyVYYzLtI
RT @ericdeinmd: #ACR21 2022 ACR/EULAR GPA Criteria
▶️Classification, NOT diagnostic!
⭐️Clinical, lab, imaging, a

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 2022 ACR/EULAR GPA Criteria ▶️Classification, NOT diagnostic! ⭐️Clinical, lab, imaging, and biopsy criteria ⭐️+5 pts for cANCA or PR3, negative pts for pANCA or MPO, or eosinophilia @RheumNow https://t.co/6YWmabNzuH https://t.co/vg8zaFt5dR
RT @ericdeinmd: #ACR21 TM26. Familial chilblains lupus seen in genetic mutation in Three Prime Repair Exonuclease 1 (TRE

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 TM26. Familial chilblains lupus seen in genetic mutation in Three Prime Repair Exonuclease 1 (TREX1). Suspected due to onset in infancy. @Rheumnow https://t.co/ZryOpeoJT8 https://t.co/LqZqoGDAL2
RT @Doctorkuch: #ACR21 Late breaking
#ACRambassador
Breakthrough COVID-19 Infections Post-vaccination Among Immunocompr

Marie Kuchynski MD Doctorkuch

4 years 10 months ago
#ACR21 Late breaking #ACRambassador Breakthrough COVID-19 Infections Post-vaccination Among Immunocompromised Patients with Autoimmune or Inflammatory Rheumatic Diseases: A Retrospective Cohort Analysis from a U.S. Nationally-sampled EMR Data Repository https://t.co/oyovR27Upm
RT @rheumarhyme: #ACR21 [Dr Pooni] #Telemedicine #Pediatrics providers felt PE was worsened BUT msk exam was the MOST re

LiSa ◡̈︎ rheumarhyme

4 years 10 months ago
#ACR21 [Dr Pooni] #Telemedicine #Pediatrics providers felt PE was worsened BUT msk exam was the MOST reliable. @endocrine_witch @millennialpedia https://t.co/3FGCyBIxB2 https://t.co/fgwdk0WXKm
RT @AshimaMakol: 👌Superb review of #SSc ILD by @sclerodermaUM #ACR21

👉EARLY/SUBCLINICAL is NOT Mild ILD
👉MMF 1

Ashima Makol MD AshimaMakol

4 years 10 months ago
👌Superb review of #SSc ILD by @sclerodermaUM #ACR21 👉EARLY/SUBCLINICAL is NOT Mild ILD 👉MMF 1st 👉TCZ in combination for progressive phenotype/progression 👉Nintedanib:start slow, uptitrate for GI tolerability 👉Early HSCT referral (early dcSSc, FVC&DLCO 45-80%, Normal🫀) https://t.co/MUOhc3PakH
RT @EBRheum: ACR/EULAR Classification Criteria for ANCA vasculitis, updated from prior

Similar disclaimer; these are f

Mike Putman EBRheum

4 years 10 months ago
ACR/EULAR Classification Criteria for ANCA vasculitis, updated from prior Similar disclaimer; these are for use AFTER the diagnosis of small or medium vasculitis has been made Great international effort, kudos to all involved #ACR21 #ACRambassador https://t.co/a29TVvzVF7
RT @KDAO2011: @ACRheum This 👇👇👇idea from @nighat
I moderated a panel of women leaders in a virtual world - one

TheDaoIndex KDAO2011

4 years 10 months ago
@ACRheum This 👇👇👇idea from @nighat I moderated a panel of women leaders in a virtual world - one of the attendees is a trainee from a 3rd world country and had a hard time finding ways to get help/collaboration for research studies; she wanted to know what she could do #ACR21 https://t.co/4Jn8jYUXME
×